[Event Report] Worldwide Simultaneous Event “The Role of Think Tanks ～Shaping Future with HGPI～” (January 30, 2018)
date : 1/30/2018
Tags: Other activities
Thank you for your continued support for the Health and Global Policy Institute(HGPI). HGPI has been working to help citizens shape health policies by generating policy options and bringing stakeholders together as a non-partisan think-tank since our establishment in 2004. Thanks to everyone’s continued support, we are pleased to announce that HGPI was once again ranked highly for the 9th consecutive year in the University of Pennsylvania’s 2017 Global Go To Think Tank Index Report.
The 2017 edition of the Index was published on January 30, 2018. In commemoration of that, many simultaneous events were organized by research institutions all around the world to discuss the role of think tanks. HGPI also convened an event on that day entitled, “The Role of Think Tanks ? Shaping the Future with HGPI ?.” The goal of the event was to review our activities, focusing on project reports from FY2017, and to discuss project plans for FY2018. There was also a discussion panel featuring multiple stakeholders on the role of think tanks in general, and HGPI specifically. We shared opinions on how to improve our activities.
Over 175 organizations worldwide in over 100 cities hosted Why Think Tanks Matter Events on January 30, 2018.
Welcoming Remarks: Ryoji Noritake (President, HGPI)
Mr. Noritake introduced the meeting and announced our position in the Index.
HGPI is now ranked 4th among global health policy think tanks (previously 6th), and ranked 3rd among domestic health policy think tanks (previously 11th).
-For more information, please see:
Project Report for FY 2017:
- Ryoji Noritake (President, HGPI)
- Mariko Oyamada (Vice President, HGPI)
Mr. Noritake explained the direction for future activities, while Ms. Oyamada explained the current state of HGPI, including its organizational structure and key performance indicators. Ms. Oyamada also explained HGPI’s current agenda and discussed its sustainability as a non-profit organization.
- Mamoru Ichikawa (Principal Program Director, Production Center I Science Programs Division, Program Production Department, Japan Broadcasting Corporation (NHK))
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Toshio Tamamuro (CSR Head, Corporate Communications & Public Affairs, Takeda Pharmaceutical Co. Ltd.)
- Sayaka Tomihara (Deputy Director, Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry (METI))
- Izumi Hamada (Vice President, Integrated Market Access, Janssen Pharmaceutical Companies of Johnson & Johnson)
- Ryoji Noritake (President, HGPI)
The panel discussion featured a lively exchange between the panelists and the audience on the various topics already presented during the meeting. A new system was used for this discussion, in which questions submitted via the internet were answered in real-time during the discussion.
What is the Role of Think Tanks in Japan?
The meeting also had a comprehensive discussion on the role of not only HGPI, but think tanks in general, including about the roles that think tank should fulfill and the issues of each stakeholder. Panelists and audience members shared comments including, “I want you to create a place where people can share their ideas equally so that everyone can go act beyond their respective positions and work towards common goals,” “It is important to widely disseminate various proposals by involving members of the media and to raise issues among the public.” Many expressed the hope that HGPI would fulfill a unique role as a stakeholder that does not directly implement policy.
What is the Role of HGPI?
Following the discussion on the role of think tanks, panelists and audience members offered many points of view on HGPI in relation to progress on innovation and globalization in the healthcare field. Comments included “I would like you to continue discussing the value of innovation and the creation of a sustainable healthcare system,” and “I hope that HGPI will maintain both a local and global perspective, and not only bring in multiple stakeholders to make proposals, but also go one step further toward giving rise to action.” Many encouraging remarks were received towards HGPI’s activities in the coming fiscal year.
- Kiyoshi Kurokawa (Chairman, HGPI)
Dr. Kiyoshi Kurokawa, Chairman of HGPI, expressed his gratitude to all participants and discussed the sense of crisis he feels about the various problems facing Japan, including the declining birthrate and aging population. He emphasized that everyone must be aware of their own strengths and weaknesses and should act to solve problems by themselves.
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)